Kairos Therapeutics.

John and a team of researchers at Kairos Therapeutics have developed a novel technology to arm antibodies and other targeting proteins with high potency poisons that could be used to specifically kill cancer cells. Kairos teamed up with scientists at VAR2 Pharmaceuticals, led by Drs. Mads Daugaard and Ali Salanti, and jointly they demonstrated that the glucose molecule is actually a focus on for anti-cancer medications, and that the VAR2CSA malarial proteins could provide the tool for delivering Kairos’ potent cancer killing toxins to tumours.All of these projections anticipate a future with a dramatic increase in the number of people who have Alzheimer's and should compel us to get ready for it, said Weuve.

Can positive video games make us better people? A computer simulation presenting people temporary superpowers could possibly cause them to behave even more empathetically in true to life, according to a scholarly study conducted by researchers from Stanford University and published in the journal PLOS ONE.